10x Genomics Inc Ordinary Shares - Class A TXG
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
10x Genomics Announces Sentira, a New Computational Platform to Turn Complex Biological Data Into Experimental Conclusions
-
10x Genomics Begins Global Shipments of Atera, Putting Unprecedented Spatial Biology Capabilities in Researchers' Hands
-
10x Genomics Wins Patent Infringement Verdict Against Parse Biosciences
-
10x Genomics Reports Second Quarter 2026 Financial Results
-
10x Genomics and Lausanne University Hospital Collaborate to Advance Research in Diagnostic Applications of Single Cell and Spatial Technologies for Cancer Care
-
10x Genomics to Report Second Quarter 2026 Financial Results on August 6, 2026
Trading Information
- Previous Close Price
- $88.76
- Day Range
- $88.14–94.56
- 52-Week Range
- $11.16–95.16
- Bid/Ask
- $93.50 / $94.20
- Shares Outstanding
- 130.29M
- Market Cap
- $12.18B
- Volume/Avg
- 3M / 3M
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 18.37
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 1,178
- Website
- https://www.10xgenomics.com
Valuation
|
Metric
|
TXG
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 14.01 |
Price/Sales | 18.37 |
Price/Cash Flow | 150.10 |
Price/Earnings
TXG
Financial Strength
|
Metric
|
TXG
|
|---|---|
Quick Ratio | 5.09 |
Current Ratio | 5.69 |
Interest Coverage | — |
Quick Ratio
TXG
Profitability
|
Metric
|
TXG
|
|---|---|
Return on Assets (Normalized) | 0.17% |
Return on Equity (Normalized) | 0.22% |
Return on Invested Capital (Normalized) | −1.76% |
Return on Assets
TXG
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|CS<PhDd | LOCK|bzW! | $167B | |||
| Medtronic PLC
MDT
| LOCK|&%$l%Cw | LOCK|n@?C | $111B | |||
| Stryker Corp
SYK
| LOCK|vxY$%l$C | LOCK|l&y | $105B | |||
| Boston Scientific Corp
BSX
| LOCK|?MCs$# | LOCK|##Y& | $63B | |||
| Edwards Lifesciences Corp
EW
| LOCK|w??Bl&^h | LOCK|WF!$^ | $49B | |||
| DexCom Inc
DXCM
| LOCK|^Rd<qSm | LOCK|q?lk | $33B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|$!hHW> | LOCK|#lP | $29B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|Zc | LOCK|rn! | $23B | |||
| Steris PLC
STE
| LOCK|WSTN$Z& | LOCK|%T$< | $20B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|QpLw>@#p | LOCK|!JG | $17B |
United States